Edition:
United States

People: United Technologies Corp (UTX.N)

UTX.N on New York Stock Exchange

101.60USD
30 Sep 2016
Change (% chg)

$0.54 (+0.53%)
Prev Close
$101.06
Open
$101.68
Day's High
$102.03
Day's Low
$101.06
Volume
1,499,528
Avg. Vol
1,135,636
52-wk High
$109.83
52-wk Low
$83.39

Garnier, Jean-Pierre 

Dr. Jean-Pierre Garnier, Ph.D., serves as an Independent Director of United Technologies Corp. Dr. Garnier is Chairman of Actelion Ltd. (biopharmaceuticals) and an Operating Partner at Advent International (global private equity). He served as CEO of Pierre Fabre SA from 2008 to 2010 and as CEO and Executive Member of the Board of Directors of GlaxoSmithKline plc from 2000 to 2008. In 2000 he served as CEO of SmithKline Beecham plc, where he had been Chief Operating Officer and Executive Member of the Board of Directors from 1996 to 2000. Dr. Garnier is a director of Renault S.A. and Radius Health, Inc. and the Board Chair of Alzheon, Inc. (non-public). Dr. Garnier served as Chairman of NormOxys, Inc. (biopharmaceuticals) from 2010 to 2011. He serves on the Advisory Board of the Newman’s Own Foundation and is a former member of the Stanford Advisory Council on Interdisciplinary Biosciences, the Board of Overseers of Weill Cornell Medical College and the Dubai International Capital Advisory Board. In 2009, he was made a Knight Commander of the British Empire and in 2007 was named Officier de la Légion d’Honneur of France.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Awards, USD 305,000
Long-Term Incentive Plans, USD --
All Other, USD 1,107
Fiscal Year Total, USD 306,107

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --